EMH:CC News and Press, Emerald Health Therapeutics Inc. From 08/12/22

Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing an update and additional background on its transaction (the "Transaction") with Skye Bioscience Inc. (OTCQB: SKYE) ("Skye...

Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announces that it has identified matters which require the Company to make restatements (the "Restatements") in respect of its interim cons...

Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc. Canada NewsWire MONTREAL , Aug. 4, 2022 /CNW Telbec/ - Certain shareholders (the " Opposing Shareholders ") of Emerald Health Therapeuti...

Vancouver, British Columbia--(Newsfile Corp. - July 12, 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH) (OTCQB: EMHTF) reports that it has received an Order of the British Columbia Securities Commission ("BCSC") revoking the management cease trade order ("MCTO...

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") has reported financial results for the quarter ended March 31, 2021. Through the first quarter of 2022 the Company continued to execute on ...

Company also provides bi-weekly MCTO status update Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF)  ("Emerald" or the "Company") has reported financial results for the year ended December 31, 2021, and an update o...

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Managemen...

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2022) - Emerald Health Therapeutics, Inc.  (CSE: EMH) (OTCQX: EMHTF)  (" Emerald " or the " Company ") is providing a status report in accordance with the alternative information guidelines set out in National Policy 12-203 ...

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc.  (CSE: EMH) (OTCQB: EMHTF)  (" Emerald " or the " Company ") is providing a default status report in accordance with the alternative information guidelines set out in National Policy...

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that it has transferred its US listing to the OTCQB after receiving notice from the OTC Markets Group that the Company no longe...